BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24916786)

  • 1. A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned.
    Miller MJ; Allison JJ; Cobaugh DJ; Ray MN; Saag KG
    J Eval Clin Pract; 2014 Oct; 20(5):638-48. PubMed ID: 24916786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.
    Fry RB; Ray MN; Cobaugh DJ; Weissman NW; Kiefe CI; Shewchuk RM; Saag KG; Curtis JR; Allison JJ
    Arthritis Rheum; 2007 Dec; 57(8):1539-45. PubMed ID: 18050227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effectiveness of a patient storytelling DVD intervention to encourage physician-patient communication about nonsteroidal anti-inflammatory drug (NSAID) use.
    Miller MJ; Weech-Maldonado R; Outman RC; Ray MN; Gary LC; Chen L; Cobaugh DJ; Allison JJ; Saag KG
    Patient Educ Couns; 2016 Nov; 99(11):1837-1844. PubMed ID: 27380647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.
    Koffeman AR; Valkhoff VE; Celik S; W't Jong G; Sturkenboom MC; Bindels PJ; van der Lei J; Luijsterburg PA; Bierma-Zeinstra SM
    Br J Gen Pract; 2014 Apr; 64(621):e191-8. PubMed ID: 24686883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness.
    Miller MJ; Schmitt MR; Allison JJ; Cobaugh DJ; Ray MN; Saag KG
    Ann Pharmacother; 2010 Feb; 44(2):274-84. PubMed ID: 20103612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients' risk awareness.
    Schmitt MR; Miller MJ; Harrison DL; Farmer KC; Allison JJ; Cobaugh DJ; Saag KG
    Patient Educ Couns; 2011 Jun; 83(3):391-7. PubMed ID: 21129892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies.
    López-Pintor E; Lumbreras B
    Int J Clin Pharm; 2011 Apr; 33(2):155-64. PubMed ID: 21394571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk Knowledge.
    van den Bogert CA; Miller MJ; Cobaugh DJ; Chen L; Allison JJ; Saag KG
    J Patient Saf; 2017 Dec; 13(4):217-222. PubMed ID: 25275383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007.
    LaCivita C; Funkhouser E; Miller MJ; Ray MN; Saag KG; Kiefe CI; Cobaugh DJ; Allison JJ
    J Am Pharm Assoc (2003); 2009; 49(5):e110-7. PubMed ID: 20797933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population.
    Modig S; Elmståhl S
    Int J Clin Pharm; 2018 Aug; 40(4):870-877. PubMed ID: 29460083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.
    Pham TT; Miller MJ; Harrison DL; Lloyd AE; Crosby KM; Johnson JL
    J Eval Clin Pract; 2013 Dec; 19(6):1026-34. PubMed ID: 23163341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial.
    Ray WA; Stein CM; Byrd V; Shorr R; Pichert JW; Gideon P; Arnold K; Brandt KD; Pincus T; Griffin MR
    Med Care; 2001 May; 39(5):425-35. PubMed ID: 11317091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period.
    Wuytack F; Smith V; Cleary BJ
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011352. PubMed ID: 27412362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial.
    Stein CM; Griffin MR; Taylor JA; Pichert JW; Brandt KD; Ray WA
    Med Care; 2001 May; 39(5):436-45. PubMed ID: 11317092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis.
    Delaney JA; Biggs ML; Kronmal RA; Psaty BM
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):83-9. PubMed ID: 21182156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.
    Jones P; Dalziel SR; Lamdin R; Miles-Chan JL; Frampton C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD007789. PubMed ID: 26130144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.
    Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
    Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings.
    Rockwell MS; Oyese EG; Singh E; Vinson M; Yim I; Turner JK; Epling JW
    BMJ Open; 2024 Apr; 14(4):e078808. PubMed ID: 38631836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Usage and co-prescription with other potentially interacting drugs in elderly: A cross-sectional study.
    Abdu N; Mosazghi A; Teweldemedhin S; Asfaha L; Teshale M; Kibreab M; Anand IS; Tesfamariam EH; Russom M
    PLoS One; 2020; 15(10):e0238868. PubMed ID: 33035226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.